Sumita Ray - Net Worth and Insider Trading

Sumita Ray Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sumita Ray owns 4 companies in total, including Calithera Biosciences Inc (CALA) , Instil Bio Inc (TIL) , and Biomea Fusion Inc (BMEA) among others .

Click here to see the complete history of Sumita Ray’s form 4 insider trades.

Insider Ownership Summary of Sumita Ray

Ticker	Comapny	Transaction Date	Type of Owner
CALA	Calithera Biosciences Inc	2017-09-29	See Remarks
TIL	Instil Bio Inc	2022-05-03	Chief Legal and Admin Officer
BMEA	Biomea Fusion Inc	2022-03-03	director
		2023-10-01	Chief Legal Officer & Secretary

Sumita Ray Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sumita Ray Ownership Network

Ownership Network List of Sumita Ray

No Data

Ownership Network Relation of Sumita Ray

Sumita Ray Owned Company Details

What does Calithera Biosciences Inc do?

Who are the key executives at Calithera Biosciences Inc?

Sumita Ray is the See Remarks of Calithera Biosciences Inc. Other key executives at Calithera Biosciences Inc include director & 10 percent owner Deepika Pakianathan , 10 percent owner Takeda Ventures, Inc. , and SR. VP & CLINICAL DEVELOPMENT Keith Orford .

Calithera Biosciences Inc (CALA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Calithera Biosciences Inc Insider Transactions

No Available Data

What does Instil Bio Inc do?

Who are the key executives at Instil Bio Inc?

Sumita Ray is the Chief Legal and Admin Officer of Instil Bio Inc. Other key executives at Instil Bio Inc include Chief Operating Officer Timothy L. Moore , director & 10 percent owner Jack Nielsen , and 10 percent owner Vivo Capital Fund Ix, L.p. .

Instil Bio Inc (TIL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Instil Bio Inc (TIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Instil Bio Inc (TIL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Instil Bio Inc (TIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Instil Bio Inc Insider Transactions

No Available Data

What does Biomea Fusion Inc do?

Who are the key executives at Biomea Fusion Inc?

Sumita Ray is the director of Biomea Fusion Inc. Other key executives at Biomea Fusion Inc include Chief Financial Officer Franco Valle , Chief Medical Officer Juan Pablo Frias , and 10 percent owner A2a Pharmaceuticals, Inc. .

Biomea Fusion Inc (BMEA) Insider Trades Summary

Over the past 18 months, Sumita Ray made no insider transaction in Biomea Fusion Inc (BMEA). Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net sale of 400,000 shares made by A2a Pharmaceuticals, Inc. , a net purchase of 12,509 shares made by Franco Valle , and a net purchase of 10,000 shares made by Hitchcock Michael J.m. .

In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 400,000 shares of Biomea Fusion Inc (BMEA) were sold and 22,509 shares were bought by its insiders, resulting in a net sale of 377,491 shares.

Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biomea Fusion Inc Insider Transactions

No Available Data

What does Vaxxinity Inc do?

Who are the key executives at Vaxxinity Inc?

Sumita Ray is the Chief Legal Officer & Secretary of Vaxxinity Inc. Other key executives at Vaxxinity Inc include 10 percent owner Prime Movers Lab Fund I Lp , 10 percent owner United Biomedical Inc , and director & 10 percent owner & See Remarks Mei Mei Hu .

Vaxxinity Inc (VAXX) Insider Trades Summary

Over the past 18 months, Sumita Ray made no insider transaction in Vaxxinity Inc (VAXX). Other recent insider transactions involving Vaxxinity Inc (VAXX) include a net sale of 96,936 shares made by Prime Movers Lab Fund I Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Vaxxinity Inc (VAXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 96,936 shares of Vaxxinity Inc (VAXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 96,936 shares.

Vaxxinity Inc (VAXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vaxxinity Inc Insider Transactions

No Available Data

Sumita Ray Mailing Address

Above is the net worth, insider trading, and ownership report for Sumita Ray. You might contact Sumita Ray via mailing address: C/o Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale Ca 94085.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.